Literature DB >> 3709627

Single dose oxazepam has no effect on acetaminophen clearance or metabolism.

J Sonne, H E Poulsen, P B Andreasen.   

Abstract

The metabolism of acetaminophen and oxazepam in humans is mainly dependent on the microsomal capacity for glucuronide conjugation. The clearance of acetaminophen and the formation of metabolites were evaluated in 7 patients before and during concomitant administration of oxazepam 30 mg. The subjects received a single 500 mg dose of acetaminophen i.v. and concentrations in plasma were measured for 360 minutes and in urine for 24 h in order to estimate the production of metabolites. The single therapeutic dose of oxazepam had no effect on the clearance of acetaminophen or on formation of its metabolites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709627     DOI: 10.1007/bf00614210

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Quantitative determination of the glutathione, cysteine, and N-acetyl cysteine conjugates of acetaminophen by high-pressure liquid chromatography.

Authors:  A R Buckpitt; D E Rollins; S D Nelson; R B Franklin; J R Mitchell
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

2.  Inhibition of acetaminophen glucuronidation by oxazepam.

Authors:  E Dybing
Journal:  Biochem Pharmacol       Date:  1976-06-15       Impact factor: 5.858

3.  Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.

Authors:  G Levy; J A Procknal
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

4.  Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide.

Authors:  G Levy; H Yamada
Journal:  J Pharm Sci       Date:  1971-02       Impact factor: 3.534

Review 5.  Conjugation reactions in foreign-compound metabolism: definition, consequences, and species variations.

Authors:  J Caldwell
Journal:  Drug Metab Rev       Date:  1982       Impact factor: 4.518

6.  Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyltransferases.

Authors:  J B Watkins; Z Gregus; T N Thompson; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1982-07       Impact factor: 4.219

7.  Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse.

Authors:  P Moldéus
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

8.  Phenobarbital induction does not potentiate hepatotoxicity but accelerates liver cell necrosis from acetaminophen overdose in the rat.

Authors:  H E Poulsen; A Lerche; N T Pedersen
Journal:  Pharmacology       Date:  1985       Impact factor: 2.547

9.  Dual role of glucuronyl- and sulfotransferases converting xenobiotics into reactive or biologically inactive and easily excretable compounds.

Authors:  K W Bock
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

Review 10.  Kinetics and metabolism of paracetamol and phenacetin.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

View more
  4 in total

1.  Single dose primaquine has no effect on paracetamol clearance.

Authors:  D J Back; J F Tjia
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Therapeutic doses of codeine have no effect on acetaminophen clearance or metabolism.

Authors:  J Sonne; H E Poulsen; S Loft; M Døssing; A Vollmer-Larsen; K Simonsen; H Thyssen; K Lundstrøm
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Concomitant overdosing of other drugs in patients with paracetamol poisoning.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

4.  Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.

Authors:  J Sonne; S Boesgaard; H E Poulsen; S Loft; J M Hansen; M Døssing; F Andreasen
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.